- Home
- AYTU vs EQS Comparison
AYTU vs EQS Comparison
Compare AYTU & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYTU
- EQS
- Stock Information
- Founded
- AYTU N/A
- EQS 1991
- Country
- AYTU United States
- EQS United States
- Employees
- AYTU N/A
- EQS N/A
- Industry
- AYTU Biotechnology: Pharmaceutical Preparations
- EQS Finance Companies
- Sector
- AYTU Health Care
- EQS Finance
- Exchange
- AYTU Nasdaq
- EQS Nasdaq
- Market Cap
- AYTU 11.8M
- EQS 13.9M
- IPO Year
- AYTU N/A
- EQS N/A
- Fundamental
- Price
- AYTU $2.00
- EQS $1.27
- Analyst Decision
- AYTU
- EQS
- Analyst Count
- AYTU 0
- EQS 0
- Target Price
- AYTU N/A
- EQS N/A
- AVG Volume (30 Days)
- AYTU 4.1M
- EQS 9.4K
- Earning Date
- AYTU 05-14-2025
- EQS 01-01-0001
- Dividend Yield
- AYTU N/A
- EQS N/A
- EPS Growth
- AYTU N/A
- EQS N/A
- EPS
- AYTU N/A
- EQS N/A
- Revenue
- AYTU $77,691,000.00
- EQS $1,329,000.00
- Revenue This Year
- AYTU N/A
- EQS N/A
- Revenue Next Year
- AYTU $4.60
- EQS N/A
- P/E Ratio
- AYTU N/A
- EQS N/A
- Revenue Growth
- AYTU N/A
- EQS 152.66
- 52 Week Low
- AYTU $0.95
- EQS $0.74
- 52 Week High
- AYTU $3.21
- EQS $1.52
- Technical
- Relative Strength Index (RSI)
- AYTU 60.38
- EQS 66.23
- Support Level
- AYTU $1.46
- EQS $0.97
- Resistance Level
- AYTU $2.70
- EQS $1.31
- Average True Range (ATR)
- AYTU 0.17
- EQS 0.07
- MACD
- AYTU -0.04
- EQS 0.04
- Stochastic Oscillator
- AYTU 60.67
- EQS 85.15
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invest primarily in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts and recapitalizations of existing businesses or special situations and achieve capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.